People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PierianDx, Inc. | — | Biotechnology | Series B | $41.9M | $442.8M | 2018 |
| Novamind Inc. | — | Biotechnology | Series A | $9.1M | $66.5M | 2022 |
| Tute Genomics, Inc. | — | Other Technology | Seed | $8.3M | $29.6M | 2013 |
| Novamind Ventures Inc. | — | Biotechnology | Seed | $2.2M | $78.2M | 2020 |
Reid Robison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Reid Robison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jesse Kaplan | 2 | 3 |
| Yaron Conforti | 2 | 3 |
| Yisroel Weinreb | 2 | 2 |
| Dinesh Patel | 1 | 13 |
| Charles Boorady | 1 | 8 |
| Kerry Propper | 1 | 6 |
| Mark McDonough | 1 | 5 |
| Jeff Burningham | 1 | 5 |
| Michael Sanderson | 1 | 4 |
| Ingrid Martin | 1 | 3 |
| Brian Carey | 1 | 3 |
| PETER THIERSCH | 1 | 3 |
| Jing Peng | 1 | 2 |
| Greg Fekete | 1 | 2 |
| Charles Rifici | 1 | 2 |
| Vaughn MacLellan | 1 | 2 |
| James Starr | 1 | 2 |
| Kai Wang | 1 | 2 |
| Mark Fekete | 1 | 2 |
| Dinesh J Patel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.